Observational Study on Dietary Supplement Use and Potential Interactions with Cancer Treatments in Adults

What this Trial Is About

This observational study focuses on adults diagnosed with cancer who are currently receiving anticancer treatments such as chemotherapy, hormone therapy, immunotherapy, or targeted therapies. The research aims to understand how common dietary supplement use is among cancer patients, the patterns of their use, and how these supplements might interact with anticancer medications. Researchers seek to explore the tolerance profile of these supplements and any potential drug interactions that may arise. Participants will complete a detailed, face-to-face questionnaire about their use of dietary supplements, including the types of supplements taken, how often and how long they have been used, reasons for taking them, and any perceived side effects. The study collects information on the participants anticancer treatments and other clinical data from medical records to analyze the relationship between supplement use and cancer therapies. Throughout the study, participants provide sociodemographic details and report on supplement use and possible adverse effects. Researchers will assess potential drug-supplement interactions using artificial intelligence tools at enrollment or during a single study visit. The main measurements are the prevalence of supplement use, tolerance, and drug interaction profiles. Participation involves completing the questionnaire and allowing access to medical records, with the study expected to continue until the end of 2027.

Dietary Supplements Among Cancer Patients: Tolerance, Impact on Medications, and Potential Drug Interactions